Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Saved in:
| Title: | Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. |
|---|---|
| Authors: | Gonzales D (AUTHOR), Rennard SI (AUTHOR), Nides M (AUTHOR), Oncken C (AUTHOR), Azoulay S (AUTHOR), Billing CB (AUTHOR), Watsky EJ (AUTHOR), Gong J (AUTHOR), Williams KE (AUTHOR), Reeves KR (AUTHOR), Varenicline Phase 3 Study Group (CORPORATE AUTHOR), Gonzales, David1 (AUTHOR), Rennard, Stephen I (AUTHOR), Nides, Mitchell (AUTHOR), Oncken, Cheryl (AUTHOR), Azoulay, Salomon (AUTHOR), Billing, Clare B (AUTHOR), Watsky, Eric J (AUTHOR), Gong, Jason (AUTHOR), Williams, Kathryn E (AUTHOR) |
| Source: | JAMA: Journal of the American Medical Association. 7/5/2006, Vol. 296 Issue 1, p47-55. 9p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 106251237 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gonzales+D%22">Gonzales D</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rennard+SI%22">Rennard SI</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nides+M%22">Nides M</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oncken+C%22">Oncken C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Azoulay+S%22">Azoulay S</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Billing+CB%22">Billing CB</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Watsky+EJ%22">Watsky EJ</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gong+J%22">Gong J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Williams+KE%22">Williams KE</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reeves+KR%22">Reeves KR</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Varenicline+Phase+3+Study+Group%22">Varenicline Phase 3 Study Group</searchLink> (CORPORATE AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gonzales%2C+David%22">Gonzales, David</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rennard%2C+Stephen+I%22">Rennard, Stephen I</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nides%2C+Mitchell%22">Nides, Mitchell</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oncken%2C+Cheryl%22">Oncken, Cheryl</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Azoulay%2C+Salomon%22">Azoulay, Salomon</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Billing%2C+Clare+B%22">Billing, Clare B</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Watsky%2C+Eric+J%22">Watsky, Eric J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gong%2C+Jason%22">Gong, Jason</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Williams%2C+Kathryn+E%22">Williams, Kathryn E</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22JAMA%3A+Journal+of+the+American+Medical+Association%22">JAMA: Journal of the American Medical Association</searchLink>. 7/5/2006, Vol. 296 Issue 1, p47-55. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=106251237 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jama.296.1.47 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 47 Titles: – TitleFull: Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gonzales D – PersonEntity: Name: NameFull: Rennard SI – PersonEntity: Name: NameFull: Nides M – PersonEntity: Name: NameFull: Oncken C – PersonEntity: Name: NameFull: Azoulay S – PersonEntity: Name: NameFull: Billing CB – PersonEntity: Name: NameFull: Watsky EJ – PersonEntity: Name: NameFull: Gong J – PersonEntity: Name: NameFull: Williams KE – PersonEntity: Name: NameFull: Reeves KR – PersonEntity: Name: NameFull: Varenicline Phase 3 Study Group – PersonEntity: Name: NameFull: Gonzales, David – PersonEntity: Name: NameFull: Rennard, Stephen I – PersonEntity: Name: NameFull: Nides, Mitchell – PersonEntity: Name: NameFull: Oncken, Cheryl – PersonEntity: Name: NameFull: Azoulay, Salomon – PersonEntity: Name: NameFull: Billing, Clare B – PersonEntity: Name: NameFull: Watsky, Eric J – PersonEntity: Name: NameFull: Gong, Jason – PersonEntity: Name: NameFull: Williams, Kathryn E IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 07 Text: 7/5/2006 Type: published Y: 2006 Identifiers: – Type: issn-print Value: 00987484 Numbering: – Type: volume Value: 296 – Type: issue Value: 1 Titles: – TitleFull: JAMA: Journal of the American Medical Association Type: main |
| ResultId | 1 |
